Nanoveu Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Alfred Chong

Chief executive officer

AU$280.9k

Total compensation

CEO salary percentage	86.4%
CEO tenure	6.3yrs
CEO ownership	9.7%
Management average tenure	no data
Board average tenure	2.7yrs

Recent management updates

Recent updates

Nanoveu Limited (ASX:NVU): When Will It Breakeven?

May 06

CEO Compensation Analysis

How has Alfred Chong's remuneration changed compared to Nanoveu's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	AU$281k	AU$243k	-AU$2m
Sep 30 2023	n/a	n/a	-AU$2m
Jun 30 2023	n/a	n/a	-AU$2m
Mar 31 2023	n/a	n/a	-AU$3m
Dec 31 2022	AU$185k	AU$184k	-AU$3m
Sep 30 2022	n/a	n/a	-AU$3m
Jun 30 2022	n/a	n/a	-AU$2m
Mar 31 2022	n/a	n/a	-AU$2m
Dec 31 2021	AU$230k	AU$199k	-AU$2m
Sep 30 2021	n/a	n/a	-AU$2m
Jun 30 2021	n/a	n/a	-AU$2m
Mar 31 2021	n/a	n/a	-AU$2m
Dec 31 2020	AU$288k	AU$220k	-AU$2m
Sep 30 2020	n/a	n/a	-AU$2m
Jun 30 2020	n/a	n/a	-AU$2m
Mar 31 2020	n/a	n/a	-AU$3m
Dec 31 2019	AU$287k	AU$218k	-AU$3m
Sep 30 2019	n/a	n/a	-AU$3m
Jun 30 2019	n/a	n/a	-AU$3m
Mar 31 2019	n/a	n/a	-AU$2m
Dec 31 2018	AU$231k	AU$168k	-AU$2m

Compensation vs Market: Alfred's total compensation ($USD185.58K) is below average for companies of similar size in the Australian market ($USD295.83K).

Compensation vs Earnings: Alfred's compensation has increased whilst the company is unprofitable.

CEO

Alfred Chong

6.3yrs

Tenure

AU$280,901

Compensation

Mr. Alfred Chong, BSc, MBA serves as Chief Executive Officer at Nanoveu Limited and serves as its Director since February 14, 2018 and serves as its Managing Director and served as its Executive Chairman u...

Board Members

Name	Position	Tenure	Compensation	Ownership
Alfred Chong	MD, CEO & Director	6.3yrs	AU$280.90k	9.72% A$ 736.4k
Steven Apedaile	Independent Non-Executive Director	6yrs	AU$63.14k	0.45% A$ 34.0k
Scott Beeton	Non-Executive Director	2.7yrs	AU$34.08k	no data
Michael Winlo	Non-Executive Director	1.2yrs	AU$45.47k	0.078% A$ 5.9k
David Pevcic	Independent Non-Executive Chairman	1.3yrs	AU$64.05k	0.53% A$ 40.4k

2.7yrs

Average Tenure

Experienced Board: NVU's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Nanoveu Management

Management criteria checks 1/4

Key information

Recent management updates

Nanoveu Limited, Annual General Meeting, May 31, 2024

Less than half of directors are independent

Nanoveu Limited Announces Change of Chief Financial Officer

Nanoveu Limited Announces Change of Chief Financial Officer

Nanoveu Limited, Annual General Meeting, May 31, 2023

Nanoveu Limited Appoints David Pevcic as Director and Non-Executive Chairman

Recent updates

Nanoveu Limited, Annual General Meeting, May 31, 2024

Less than half of directors are independent

Nanoveu Limited has completed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Nanoveu Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Nanoveu Limited Announces Change of Chief Financial Officer

Nanoveu Limited Announces Change of Chief Financial Officer

Nanoveu Limited, Annual General Meeting, May 31, 2023

Full year 2022 earnings released: AU$0.012 loss per share (vs AU$0.013 loss in FY 2021)

Nanoveu Limited Appoints David Pevcic as Director and Non-Executive Chairman

Less than half of directors are independent

Less than half of directors are independent

First half 2022 earnings released: AU$0.006 loss per share (vs AU$0.007 loss in 1H 2021)

Nanoveu Limited Announces Resignation of Mr. Scott Beeton as A Director Effective 31 August 2022

Insider recently bought AU$367k worth of stock

Nanoveu Limited, Annual General Meeting, May 31, 2022

Less than half of directors are independent

Nanoveu Limited Receives Approval for the Registration of its Nanoshield Film Line

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Nanoveu Limited Announces Retirement of David Nicol as Director

Nanoveu Limited Launches Spray Coating Effective Against MHV-A59

Nanoveu Limited announced that it expects to receive AUD 1.35 million in funding

Nanoveu Limited (ASX:NVU): When Will It Breakeven?

Nanoveu Limited Launches Product Development Update and Outdoor Test Results

Nanoveu Limited Executes A 12-Month Exclusive Distribution Agreement (The Agreement) with Cuvira Limited (Cuvira)

Nanoveu Limited announced that it expects to receive AUD 0.66 million in funding

Nanoveu Limited Announces Advanced Prototype of EyeFyx Product

Nanoveu Limited Secures New Sales for its B2B Antiviral Film and Antiviral Mobile Phone Protection Product

Nanoveu Limited announced that it expects to receive AUD 2.4 million in funding from Antiviral technologies portfolio LLC

CEO Compensation Analysis

CEO

Tenure

Compensation

Board Members

Average Tenure